Resmed 

A$34.11
314
+A$0.4+1.19% Friday 06:10

统计数据

当日最高
34.34
当日最低
34.02
52周最高
34.34
52周最低
21.14
成交量
1,645,595
平均成交量
1,800,238
市值
31.82B
市盈率
33.2
股息收益率
0.93%
股息
0.32

即将到来

股息

0.93%股息收益率
10年增长
6.66%
5年增长
5.85%
3年增长
7.63%
1年增长
9.78%

收益

24Oct已确认
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
1.59
1.77
1.95
2.13
预期每股收益
2.054554
实际每股收益
N/A

人们还关注

此列表基于关注RMD.AU的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。
Koninklijke Philips N.V.
PHG
市值27.04B
飞利浦的子公司飞利浦呼吸疗法与ResMed直接竞争,提供CPAP机、通风机和其他呼吸产品,在睡眠和呼吸护理市场上。
Medtronic
MDT
市值105.2B
美敦力提供一系列医疗设备,与ResMed竞争,尤其是呼吸系统的通风和监测系统。
Boston Scientific
BSX
市值112.2B
波士顿科学公司在医疗设备领域与ResMed竞争,尤其是通过其各种医疗解决方案在睡眠和呼吸护理方面。
GE Aerospace
GE
市值181.22B
通用电气通过其医疗保健部门提供与ResMed的产品竞争的医疗设备和技术,包括呼吸护理和睡眠解决方案。
Smith & Nephew
SNN
市值13.06B
Smith & Nephew虽然以骨科为主要业务,但通过其医疗设备部门与ResMed竞争,包括与睡眠相关疾病护理有交集的伤口管理设备。
Stryker
SYK
市值124.93B
Stryker在更广泛的医疗技术和设备市场上与ResMed竞争,提供可用于外科手术和重症监护环境的产品,可能与ResMed的市场重叠。
Zimmer Biomet
ZBH
市值22.01B
Zimmer Biomet主要专注于肌肉骨骼保健,与ResMed在医疗设备市场上竞争,提供间接影响睡眠和呼吸健康的产品。
Hologic
HOLX
市值19.43B
Hologic提供医疗设备和技术,与ResMed竞争,特别是通过其成像和数字健康解决方案在睡眠障碍的诊断和治疗方面。
Intuitive Surgical
ISRG
市值164.68B
以其机器人手术系统而闻名的Intuitive Surgical在更广泛的医疗技术领域与ResMed竞争,提供创新解决方案,可以影响与睡眠和呼吸护理相关的疾病的治疗。

分析师评级

227A$平均价格目标
最高估值为 A$251。
来自过去6个月内的 6 个评级。这不是投资建议。
买入
50%
持有
50%
卖出
0%

关于

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Show more...
首席执行官
Mr. Michael J. Farrell BE, MBA, SM
国家
AU
ISIN
AU000000RMD6
WKN
000935168

上市公司